2-((3-Amino-6-chloropyrazine-2-carboxamido)methyl)-5-(2-((2-((dimethylphosphoryl)methoxy)ethyl)amino)-2-oxoethoxy)-1,3-diethyl-1H-benzo[d]imidazol-3-ium

Catalog No. :
ACILOA425
CAS No. :
2084037-36-3
Molecular Formula :
C24H34ClN7O5P+
Molecular Weight :
567.01

IUPAC Name:2-((3-amino-6-chloropyrazine-2-carboxamido)methyl)-6-(2-((2-((dimethylphosphoryl)methoxy)ethyl)amino)-2-oxoethoxy)-1,3-diethyl-1H-benzo[d]imidazol-3-ium

2-((3-Amino-6-chloropyrazine-2-carboxamido)methyl)-5-(2-((2-((dimethylphosphoryl)methoxy)ethyl)amino)-2-oxoethoxy)-1,3-diethyl-1H-benzo[d]imidazol-3-ium structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((3-Amino-6-chloropyrazine-2-carboxamido)methyl)-5-(2-((2-((dimethylphosphoryl)methoxy)ethyl)amino)-2-oxoethoxy)-1,3-diethyl-1H-benzo[d]imidazol-3-ium
IUPAC Name2-((3-amino-6-chloropyrazine-2-carboxamido)methyl)-6-(2-((2-((dimethylphosphoryl)methoxy)ethyl)amino)-2-oxoethoxy)-1,3-diethyl-1H-benzo[d]imidazol-3-ium
Molecular FormulaC24H34ClN7O5P+
Molecular Weight567.01
SMILESO=C(C1=NC(Cl)=CN=C1N)NCC2=[N+](CC)C3=C(C=CC(OCC(NCCOCP(C)(C)=O)=O)=C3)N2CC
InChI KeyDXVNYGRCASBPNU-UHFFFAOYSA-O
CAS No.2084037-36-3

Synthetic Route by SureRoute

1. ACILOA425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACILOA425 route product structure diagram
    ACILOA4252084037-36-3
Inquiry

2. ACILOA425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVJPE175 route compound structure diagram
    ACVJPE1751458-03-3 In Stock
  4. Then
  5. ACILOA425 route product structure diagram
    ACILOA4252084037-36-3
Inquiry

Comments (0)